2024 journal article
Mutant Nrf2<SUP>E79Q</SUP> enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
REDOX BIOLOGY, 75.
Squamous cell carcinomas (SCCs), including lung, head & neck, bladder, and skin SCCs often display constitutive activation of the KEAP1-NRF2 pathway. Constitutive activation is achieved through multiple mechanisms, including activating mutations in NFE2L2 (NRF2). To determine the functional consequences of Nrf2 activation on skin SCC development, we assessed the effects of mutant Nrf2